Plantimex Mamisan Lidocaine Ointment Containers Recall

Serious Injury or Death from Child Poisoning.

CPSC recall #26157 · announced Dec 18, 2025 · verified Jul 30, 2026

Hazard

The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.

Remedy

Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.

Units

About 50,330

Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

How to identify the recalled product

Product	Mamisan Pain Relieving Topical Ointment
Manufacturer / importer	MiramarLab, of Doral, Florida
Units recalled	About 50,330

The recall

This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.

Reported incidents

None reported

What consumers should do now

Stop using the recalled product immediately. Contact the company for the announced remedy. Do not resell or donate recalled products — it is illegal under federal law.

Plantimex toll-free at 855-752-6869 from 9 a.m. to 4 p.m. PT Monday through Friday, email at [email protected] with the subject "RECALL" or online at http://plantimexusa.com/contact.php or www.plantimexusa.com and contact us for more information.

Source: U.S. Consumer Product Safety Commission. Official notice title: “Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging”. Read the official CPSC notice